5 NASDAQ Penny Stocks Under 10 Cents
Newcourt Acquisition Corp (NASDAQ:NCACW) is a blank check company formed for the purpose of acquiring businesses through a merger, capital exchange, asset acquisition, stock purchase, reorganization, ...
Contrafect Corp (CFRX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 4,095,150 | $393,134 | 0% | |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 86,900 | $8,342 | -15% | 0% |
| 3. | Citadel Investment Group Ken Griffin | 75,164 | $7,215 | -81% | 0% |
| 4. | 23,300 | $2,237 | -37% | 0% | |
| 5. | Renaissance Technologies Jim Simons | 477,900 | $46 | +278% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.37 | 5,000 | Officer | 19,091 | 2019-12-13 | Filing | |
| $0.39 | 50,000 | Director | 62,000 | 2019-12-13 | Filing | |
| $0.43 | 300,000 | Director | 370,550 | 2019-12-13 | Filing | |
| $1.24 | 16,000 | Director | 16,000 | 2017-07-25 | Filing | |
| $1.24 | 2,000 | Officer | 2,000 | 2017-07-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.04 | 600,000 | Large Shareholder | 7,900,000 | 2018-12-04 | Filing | |
| $2.04 | 600,000 | Large Shareholder | 7,900,000 | 2018-12-04 | Filing | |
| $3.81 | 2,872 | Officer | 0 | 2015-11-17 | Filing | |
| $4.23 | 2,867 | Officer | 2,872 | 2015-11-03 | Filing | |
| $4.48 | 2,867 | Officer | 5,739 | 2015-10-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 745,385 | $74,539 | 0% | |
| 2. | 519,432 | $49,867 | 0% | |
| 3. | 423,968 | $40,701 | 0% | |
| 4. | 187,551 | $18,005 | 0% | |
| 5. | 157,612 | $15,131 | 0% |
News See All
Were Hedge Funds Right About ContraFect Corp (CFRX)?
In this article we will analyze whether ContraFect Corp (NASDAQ:CFRX) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas.
Is CFRX A Good Stock To Buy Now?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 817 active prominent money managers and analyze their...
Hedge Funds Never Been Less Bullish On ContraFect Corp (CFRX)
In this article you are going to find out whether hedge funds think ContraFect Corp (NASDAQ:CFRX) is a good investment right now.
Were Hedge Funds Right About Dumping ContraFect Corp (CFRX)?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Is ContraFect Corp (CFRX) A Good Stock To Buy?
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing where to invest this...
13G Filing: 683 Capital Partners and Contrafect Corp (CFRX)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing ...
13G Filing: Biotechnology Value Fund LP and Contrafect Corp (CFRX)
You can access the original SEC filing by clicking here.
Is ContraFect Corp (CFRX) A Good Stock To Buy?
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3
Baker Bros. Advisors has arguably been the most successful healthcare-focused hedge fund on the Street in recent years.
Billionaire Hedge Funds
